Predictors of short-term and long-term effects of mavacamten in obstructive hypertrophic cardiomyopathy

Affiliations

• ¹ Department of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ, United States.
• ² Department of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ, United States; Department of Internal Medicine, Creighton University, Phoenix, AZ, United States.
• ³ Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United States.
• ⁴ Department of Cardiovascular Diseases, Mayo Clinic, Scottsdale, AZ, United States. Electronic address: [email protected].